We're Talking About Dense Breast Tissue All Wrong: Categories A, B, C, D and What They Mean.
- 1 day ago
- 2 min read
We are talking about dense breast tissue all wrong.
And it is leaving patients more confused than informed.
———
You have probably seen the statistic.
"Up to 50% of women have dense breast tissue."
It is repeated across awareness campaigns, clinical handouts, and advocacy websites — including by well-meaning organizations doing important work.
But here is what that number leaves out:
Not all density is the same. And not all density carries the same clinical implications. By collapsing four distinct, clinically meaningful categories into a single phrase, we are failing the patients who need precision the most.
———
Here is what the science actually says.
Dense breast tissue is classified into four categories A, B, C, D and here's what they mean:
🔵 Category A — ~10% of women
Mostly fatty tissue. Standard mammography is highly effective.
🔵 Category B — ~40% of women
Scattered fibroglandular density. Does NOT meet current recommendations for supplemental screening.
🟡 Category C — ~40% of women
Heterogeneously dense. Meets recommendations for supplemental screening. Mammograms may miss cancers.
🟡 Category D — ~10% of women
Extremely dense. Meets recommendations for supplemental screening. Significantly limits mammogram sensitivity.
The real statistic?
It is not that 50% of women have dense breasts.
It is that 50% of women — Categories C and D — meet the current guidelines recommending supplemental screening beyond a standard mammogram.
That is a very different sentence. And it matters enormously.
A Category B patient may assume she needs supplemental screening. A Category C or D patient may not understand the urgent implication for this risk factor — or the necessity for additional screening, and that she has options.
Imprecise language in health education is not neutral. It has consequences.
———
This is exactly the conversation The Clear Pathways Program was built to advance.
Powered by For The Love Of Cups, we exist to elevate the standard of care — starting with elevating the standard of communication. We are not just advocating for awareness. We are advocating for precision.
———
This October, we are bringing this conversation into the room where it belongs.
The Breast Density Summit | October 8, 2026
Palo Alto, CA · Wilson Sonsini Goodrich & Rosati
Breast Cancer Awareness Month
🎗️ Attend the summit: TICKETS & SPONSORSHIPS
🧭 Join our Advisory Board: clinicians, radiologists, researchers, patient advocates, and health communications experts.
Every woman deserves to know exactly what her results mean — and exactly what to do next.
